SMTL ID : 4hcv.1

Crystal structure of ITK in complex with compound 53

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.48 Å

Oligo State

monomer

Ligands

1 x 13J: 3-{4-amino-1-[(3S)-1-propanoylpiperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-[4-(propan-2-yl)phenyl]benzamide(Covalent)

13J.1: 22 residues within 4Å: Chain A: I.18, G.19, F.23, A.38, K.40, I.42, M.47, L.82, F.84, E.85, F.86, M.87, C.91, S.93, D.94, R.135, L.138, S.148, D.149, M.152, F.155, V.156 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:I.18, A:F.23, A:A.38, A:I.42, A:M.47, A:L.82, A:L.138, A:L.138, A:F.155, A:V.156 Hydrogen bonds: A:K.40, A:E.85, A:M.87, A:D.94, A:D.149 pi-Stacking: A:F.84 pi-Cation interactions: A:K.40

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zapf, C.W. et al., Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assay. J.Med.Chem. (2012)

Release Date

2012-11-14

Peptides

Tyrosine-protein kinase ITK/TSK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ITK/TSK

Related Entries With Identical Sequence